<DOC>
	<DOC>NCT02355665</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety of a novel nicotine product for continuous abstinence from smoking. Efficacy of product will be evaluated by assessments of self-reported abstinence, verified by exhaled carbon monoxide (CO) levels.</brief_summary>
	<brief_title>Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Subjects must be males or females 1885 years of age who currently smoke cigarettes daily and are willing to stop smoking History of cardiovascular disease, stomach ulcer or diabetes unless physician's written approval is obtained. Use of other forms of tobacco/nicotine containing products other than cigarettes within 30 days before baseline visit. Use of nicotine replacement therapies or other smoking cessation medicines/nondrug therapies within 30 days before the baseline visit. Pregnancy or intending to become pregnant. Hypersensitivity to the product, history of alcohol or substance abuse.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>